(Q37909074)

25 August 2017

0 references

1 reference

title

Factor V Leiden and inflammatory bowel disease: a systematic review and meta-analysis (English)

1 reference

inflammatory bowel diseases

25 August 2017

main subject

0 references

1 reference

1 reference

Jie Liang

1

1 reference

25 August 2017

Shengjun Wu

2

1 reference

25 August 2017

Bin Feng

3

1 reference

25 August 2017

Shaoni Lei

4

1 reference

25 August 2017

Guanhong Luo

5

1 reference

25 August 2017

Jingbo Wang

6

1 reference

25 August 2017

Kai Li

7

1 reference

25 August 2017

Xiaohua Li

8

1 reference

25 August 2017

Huahong Xie

9

1 reference

25 August 2017

Dexin Zhang

10

1 reference

25 August 2017

Xin Wang

11

1 reference

25 August 2017

Kaichun Wu

12

1 reference

25 August 2017

Danmin Miao

13

1 reference

25 August 2017

Daiming Fan

14

1 reference

25 August 2017

publication date

30 July 2011

1 reference

Journal of Gastroenterology

25 August 2017

published in

1 reference

25 August 2017

volume

46

1 reference

25 August 2017

issue

10

1 reference

25 August 2017

page(s)

1158-1166

1 reference

Review article: inherited thrombophilia in inflammatory bowel disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Diagnosis of activated protein C resistance (factor V Leiden)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Prevalence of the factor V Leiden mutation in human inflammatory bowel disease with different activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Factor V Leiden mutation is not increased in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Arg506Gln factor V mutation and Val34Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Mutations in clotting factors and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Assessment of thrombophilic abnormalities during the active state of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Venous thrombosis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Thrombosis and inflammatory bowel disease-the role of genetic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Publication bias in meta-analysis: its causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Natural selection has driven population differentiation in modern humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

World distribution of factor V Leiden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Impact of race and ethnicity on inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

A rare association between ulcerative colitis (UC), celiac disease (CD), membranous glomerulonephritis, leg venous thrombosis, and heterozygosity for factor V Leiden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Budd-Chiari syndrome with underlying homozygous factor V Leiden and heterozygous methylenetetrahydrofolate reductase mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0441-7

Factor V Leiden and the etiology of inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

Inflammatory bowel disease promotes venous thrombosis earlier in life

1 reference

12 December 2020

Thrombophilia and inflammatory bowel disease: does factor V mutation have a role?

1 reference

12 December 2020

An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease

1 reference

12 December 2020

The high prevalence of the factor V Leiden mutation in central European inflammatory bowel disease patients

1 reference

12 December 2020

Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area

1 reference

12 December 2020

Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease

1 reference

12 December 2020

Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism

1 reference

12 December 2020

Genetic Risk Factors In Patients With Inflammatory Bowel Disease And Vascular Complications: Case-Control Study

1 reference

12 December 2020

Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.

1 reference

12 December 2020

Thrombosis in Inflammatory Bowel Diseases: Role of Inherited Thrombophilia

1 reference

12 December 2020

Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden

1 reference

12 December 2020

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

1 reference

12 December 2020

Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis

1 reference

12 December 2020

Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia

1 reference

12 December 2020

Prophylaxis of venous thromboembolism in IBD

1 reference

12 December 2020

Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients

1 reference

12 December 2020

10.1007/S00535-011-0441-7

Identifiers

DOI

1 reference

25 August 2017

1 reference